OR13-3 Effects of Iron Isomaltoside versus Ferric Carboxymaltose on Hormonal Control of Phosphate Homeostasis: The PHOSPHARE-IDA04/05 Randomized Controlled Trials

Iron isomaltoside (IIM) and ferric carboxymaltose (FCM) are newer intravenous iron preparations that can be administered in high-doses to rapidly correct iron deficiency anemia (IDA). FCM can cause hypophosphatemia due to fibroblast growth factor 23 (FGF23) mediated renal phosphate wasting, which ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Wolf, Myles, Rubin, Janet, Achebe, Maureen, Econs, Michael, Peacock, Munro, Imel, Erik, Thomsen, Lars, Carpenter, Thomas, Weber, Thomas, Zoller, Heinz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Bone and Mineral Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554827/
http://dx.doi.org/10.1210/js.2019-OR13-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554827/
http://dx.doi.org/10.1210/js.2019-OR13-3

Ejemplares similares